CoChat

Artificial intelligence (AI) in healthcare and biomedical research: Why a strong computational/AI bioethics framework is required?

Open access
Bali, Jatinder, Garg, Rohit, Bali, RenuT · 2019 · Indian Journal of Ophthalmology
Cited by 88

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

What is Artificial Intelligence? Artificial intelligence (AI) refers to a computer mimicking “intellectual processes characteristic of humans, such as the ability to reason, discover meaning, generalize, or learn from past experience” to achieve goals without being explicitly programmed for specific action. There is no consensus on what constitutes AI. Different criteria for intelligence proposed have not satisfied everyone leading to the famous aphorism, “AI is whatever hasn’t been done yet.” For example, optical character recognition and translation has now been relegated from “artificial intelligence” because of the routine nature of their use.[12] The broad agreement is that any device which uses reason, devises strategy, solves puzzles, and makes “judgments under uncertainty representing knowledge, including commonsense knowledge, plans, learns, communicates in natural language and integrates all these skills towards common goals” demonstrates intelligence. Currently, in 2018, we can safely place activities such as understanding human speech, competing at the highest level in strategic game systems (such as chess and Go), driving autonomous cars, planning intelligent routing in content delivery network, and military simulations in the realm of AI.[3] Some famous authors mentioned different benchmarks. The most famous was the “Turing-Test” (1950) by Alan Turing where a human who converses with an unseen machine and an unseen human must guess which of the two is the machine. The machine passes this test if it fools the evaluator for 30% of the time. In 2014, a program called Eugene Goostman cleared this test.[4] Edward Feigenbaum in 2003 tweaked the “Turing-Test” to create “Subject-Matter-Expert-Turing-Test” or the “Feigenbaum-Test” where a machine's response cannot be distinguished from an expert in a given field. These are examples of “narrow-artificial intelligence.” The next higher goal is “artificial-general-intelligence,” where a model trained on one task can be re-purposed on a second related task, a concept called transfer learning.[3] We are some distance from it today. Artificial Intelligence and Strategy Games In 1997, IBM DeepBlue became the first computer chess-playing system to beat a reigning world chess champion, Garry Kasparov, in a full series. In 2011, IBM's Watson was crowned champion for beating the two greatest Jeopardy champions, Brad Rutter and Ken Jennings. In 2016, DeepMind's AlphaGo defeated Go champion Lee Sedol in an ancient strategy game played on a “19 × 19-board,” winning 4 out of 5 games, becoming the first computer to beat a professional Go player without handicaps. In 2017, AlphaGo won a three-game match with world No. 1 ranked Ke Jie. Till now, the DeepMind was trained by human experts.[5] DeepMind AI then developed a completely self-taught program without any human intervention and called it AlphaGo Zero (AGZ). This AlphaGo Zero gained tremendous human knowledge around the game Go in just 72 hours and was called AlphaGo Zero (3 days). It beat the version of the original AlphaGo that had defeated human champion Lee Sedol with a score of 100 to 0. It did so without any human data, which usually provided the baseline to train the AI. It used spontaneous data depending only on the rules and constraints while playing repeatedly. In December 2017, another program Alpha Zero trained within 24 hours to demonstrate superhuman capabilities in Chess, Go, and Shogi together. With mere 34 hours of self-learning of Go, AlphaZero defeated its predecessor AlphaGoZero 60 wins to 40 losses. In chess, AlphaZero gave a fantastic 28 wins, 0 losses, and 72 draws. In Shogi, it recorded 90 wins, 8 losses, and 2 draws. Thus, we now had “a bot that defeated the bot that defeated the world champion human.”[5] Artificial Intelligence in Medicine AI applications have become common, e.g. Siri, Alexa, and Cortana. In medicine, IBM Watson-Oncology has picked up drugs for treatment of cancer patients with equal or better efficiency than human experts. Microsoft's Hanover Project at Oregan has analyzed medical research to tailor personalized cancer treatment option.[6] United Kingdom's National Health Service (NHS) used Google's DeepMind platform for detecting health risks by analyzing mobile app data and medical images collected from NHS patients.[7] Stanford's radiology algorithm picked up pneumonia better than human radiologists,[8] while in diabetic retinopathy challenge, the computer was as good as expert ophthalmologists in making a referral decision.[9] In 2018, Krause et al. trained an automated algorithm for diabetic retinopathy (DR) grading while working on quantifying errors in DR grading based on individual graders and the majority decision using adjudication. They retrospectively analyzed Health Insurance Portability and Accountability Act Safe Harbor deidentified images labeled by American board-certified ophthalmologists and retinal specialists in addition to the “developed and tuned” a

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/ijo.ijo_1292_18

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 88

Metadata

Authors
Bali, J., Garg, R., & Bali, R.
Venue
Indian Journal of Ophthalmology
Publisher
Medknow
Published
2019
Volume
67
Issue
1
Pages
3
ISSN
0301-4738 (ISSN-L)
OpenAlex
W2906080203
Cited by
88
References
1
FWCI
1.13
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Artificial intelligence (AI) in healthcare and biomedical research: Why a strong computational/AI bioethics framework is required? https://app.cochat.ai/papers/10.4103/ijo.ijo_1292_18
The paper
Bali, J., Garg, R., & Bali, R. (2019). Artificial intelligence (AI) in healthcare and biomedical research: Why a strong computational/AI bioethics framework is required? Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_1292_18

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.